Published 11 hours ago • loading... • Updated 4 hours ago
City Therapeutics Announces Pricing of Upsized Initial Public Offering
Summary by Globe Newswire
7 Articles
7 Articles
City Therapeutics lands $200M IPO as it builds an Alnylam 2.0 in RNAi field
City Therapeutics will be the 26th biotech to complete an initial public offering in 2026 when it begins trading Friday morning, adding to a boisterous rebound in industry listings. The Kendall Square-based drug developer priced ...
Coverage Details
Total News Sources7
Leaning Left1Leaning Right1Center1Last Updated34% Left, 33% Center, 33% Right
Bias Distribution
- 34% of the sources lean Left, 33% of the sources are Center, 33% of the sources lean Right
34% Left
L 34%
C 33%
R 33%
Factuality
To view factuality data please Upgrade to Premium









